These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9331125)

  • 1. Paclitaxel/carboplatin plus ifosfamide in non-small cell lung cancer.
    Vokes EE; Mauer AM; Hoffman PC; Masters G; Watson S; Golomb HM
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-67-S12-69. PubMed ID: 9331125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ifosfamide and paclitaxel combinations for the treatment of advanced non-small cell lung cancer.
    Shepherd FA; Eisenhauer E
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):2-7. PubMed ID: 9535204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ifosfamide-based three-drug combination regimens in non-small cell lung cancer.
    Vokes EE; Masters GA; Mauer AM; Hoffman PC; Watson S; Golomb HM
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):19-22. PubMed ID: 9535207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer.
    Bunn PA
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):18-25. PubMed ID: 9007116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions.
    Bunn PA
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-153-S12-162. PubMed ID: 9331142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent paclitaxel, carboplatin, and radiation therapy for locally advanced non-small cell lung cancer.
    Choy H; Akerley W; DeVore RF
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):36-43. PubMed ID: 10190782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of paclitaxel and carboplatin versus ifosfamide, etoposide, and carboplatin regimen for treatment of patients with advanced non-small cell lung cancer].
    Li DX; Chen XB
    Ai Zheng; 2002 Apr; 21(4):412-5. PubMed ID: 12452023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network.
    Langer CJ; Millenson M; Rosvold E; Litwin S; McAleer CA; Bonjo CA; Ozols R
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer.
    Belani CP
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):44-54. PubMed ID: 10190783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer.
    Neill HB; Miller AA; Clamon GH; Perry MC; Crawford J; Green MR
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-130-S12-134. PubMed ID: 9331137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
    Palackdharry CS
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-108-S2-112. PubMed ID: 9045327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer.
    Birch R; Weaver CH; Hainsworth JD; Bobo C; Greco FA
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-135-S12-137. PubMed ID: 9331138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: preliminary report of a phase I trial.
    Socinski MA; Clark JA; Halle J; Steagall A; Kaluzny B; Rosenman JG
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-117-S12-122. PubMed ID: 9331135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel, ifosfamide, and carboplatin for the treatment of stages IIIB and IV non-small cell lung cancer: preliminary results.
    Zaniboni A; Meriggi F; Rizzi A; Alghisi A; Pascarella A; Bozzola G; Mutti S; Marini G
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-70-S12-72. PubMed ID: 9331126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination paclitaxel and platinum in the treatment of lung cancer: US experience.
    Bunn PA
    Semin Oncol; 1996 Dec; 23(6 Suppl 15):9-15. PubMed ID: 8996590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of paclitaxel/carboplatin in advanced non-small cell lung cancer.
    Bonomi P
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):55-9. PubMed ID: 10190784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
    Herbst RS; Hammond LA; Carbone DP; Tran HT; Holroyd KJ; Desai A; Williams JI; Bekele BN; Hait H; Allgood V; Solomon S; Schiller JH
    Clin Cancer Res; 2003 Sep; 9(11):4108-15. PubMed ID: 14519633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.